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Actomyosin drives cancer cell nuclear dysmorphia
and threatens genome stability
Tohru Takaki1,2, Marco Montagner3,*, Murielle P. Serres1,4,*, Maël Le Berre5, Matt Russell6, Lucy Collinson6,
Karoly Szuhai7, Michael Howell8, Simon J. Boulton2, Erik Sahai3 & Mark Petronczki1,9
Altered nuclear shape is a defining feature of cancer cells. The mechanisms underlying
nuclear dysmorphia in cancer remain poorly understood. Here we identify PPP1R12A and
PPP1CB, two subunits of the myosin phosphatase complex that antagonizes actomyosin
contractility, as proteins safeguarding nuclear integrity. Loss of PPP1R12A or PPP1CB causes
nuclear fragmentation, nuclear envelope rupture, nuclear compartment breakdown and
genome instability. Pharmacological or genetic inhibition of actomyosin contractility restores
nuclear architecture and genome integrity in cells lacking PPP1R12A or PPP1CB. We detect
actin filaments at nuclear envelope rupture sites and define the Rho-ROCK pathway as the
driver of nuclear damage. Lamin A protects nuclei from the impact of actomyosin activity.
Blocking contractility increases nuclear circularity in cultured cancer cells and suppresses
deformations of xenograft nuclei in vivo. We conclude that actomyosin contractility is a major
determinant of nuclear shape and that unrestrained contractility causes nuclear dysmorphia,
nuclear envelope rupture and genome instability.
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A
lterations in nuclear shape and size as well as ongoing
genomic changes are defining features of cancer cells and
are used to clinically grade malignancies. The physical
properties of the nucleus are largely determined by the chromatin
contained within the nucleus and the nuclear envelope. The
nuclear envelope is composed of two lipid bilayer membranes,
nuclear pores spanning the two membranes and a network of
nuclear lamina proteins, including LMNA, LMNB1 and LAP2b,
associated with the inner membrane1,2. Disruption of LMNA and
LMNB1 function leads to altered nuclear morphology and gene
expression3. The cytoplasmic face of the nuclear envelope can be
coupled to the cytoskeleton and this linkage may influence
nuclear architecture through mechanical forces4. However, the
interplay between cytoskeletal forces and nuclear shape is not well
understood. Although nuclear dysmorphia has been used for
tumour grading in the clinic for several decades5,6, the
mechanisms underlying aberrant nuclear morphology in cancer
and their impact on genomic integrity remain largely
unaddressed6,7.
In non-muscle cells, contractile force is predominantly
generated by the action of myosin II motors on actin filaments8.
Phosphorylation of myosin regulatory light chain (MYL9) on
threonine 18 and serine 19 promotes productive actomyosin
interactions and force generation9,10. The small G-proteins RhoA
and RhoC are able to promote myosin regulatory light chain (also
known as MRLC) phosphorylation by activating the kinases
ROCK1 and ROCK2, and gain of Rho/ROCK function is linked
to aggressive tumour phenotypes11–13. De-phosphorylation of
myosin light chain is mediated by a protein phosphatase 1 (PP1)
complex containing the regulatory subunit, PPP1R12A (also
known as MYPT1)14. Thus, PPP1R12A normally functions to
restrain actomyosin contractility.
We find that actomyosin contractility is major determinant of
nuclear shape and integrity both in vitro and in vivo. We identify
myosin phosphatase as a safeguard for nuclear integrity.
Unrestrained contractility caused by loss of PPP1R12A elicits
nuclear envelope rupture and drives genome instability.
Our data suggest that nuclear dysmorphia of cancer cells and
nuclear shape in general is controlled by the opposing activities of
actomyosin contractility promoting factors and myosin
phosphatase.
Results
Myosin phosphatase safeguards nuclear integrity. In this study,
we set out to identify regulators of nuclear morphology in human
cells using functional genomics. We systematically perturbed
protein phosphorylation by using RNA interference (RNAi) to
deplete 264 phosphatase factors in HeLa cells (Supplementary
Data 1). Following siRNA transfection, the nuclear morphology
defects in cells were evaluated by microscopy (Supplementary
Fig. 1a). The top hit emerging from this analysis was PPP1R12A
(also called MYPT1, myosin phosphatase target subunit), which,
when depleted, led to highly irregular and fragmented nuclei that
diverged greatly from the simple circular form of control nuclei
(Fig. 1a,b; Supplementary Fig. 1a,b and Supplementary Movies 1
and 2). PPP1R12A is a regulator of PPP1CB (also called PP1b),
one of three enzymatic protein phosphatase 1 (PP1) genes
encoded in the human genome. The regulatory subunit
PPP1R12A directly binds to the catalytic subunit PPP1CB and is
thought to guide substrate selectivity of the latter15. The complex
of PPP1R12A and PPP1CB is also referred to as myosin
phosphatase and has been reported to dephosphorylate multiple
substrates including myosin light chain and the mitotic kinase
PLK1 (ref. 16). Consistent with complex formation between the
two PP1 subunits, PPP1CB depletion also caused a dramatic
change in nuclear morphology as well as nuclear fragmentation in
our RNAi screen, similar to depletion of PPP1R12A (Fig. 1a,b;
Supplementary Fig. 1a,b). Previous screens have also identified
PPP1R12A and PPP1CB as factors controlling nuclear
morphology17,18. However, the nature of the nuclear defect
observed in depleted cells and the function of the two proteins in
maintaining nuclear shape has not been addressed. Multiple
independent siRNA duplexes targeting PPP1R12A or PPP1CB
caused strong nuclear morphology defects (Supplementary
Fig. 1c). Expression of siRNA-resistant transgenes encoding the
phosphatase subunits PPP1R12A and PPP1CB restored normal
nuclear shape upon depletion of the endogenous counterparts
(Supplementary Fig. 2). These results demonstrate that the
phosphatase enzyme PPP1CB and its regulator PPP1R12A are
required to maintain normal nuclear morphology in cultured
human cells. Co-depletion of both phosphatase subunits did
neither suppress nor further enhance the nuclear defects observed
by individual depletion of each subunit suggesting that the
observed phenotype reflects a loss-of-function situation of the
phosphatase complex (Supplementary Fig. 1d).
Loss of PPP1R12A–PPP1CB causes nuclear lamina rupture. To
address the nature of the striking nuclear deformation caused by
depletion of PPP1R12A and PPP1CB, we first focused on the
nuclear envelope. Co-staining for nuclear envelope markers and
DNA revealed that PPP1R12A and PPP1CB depletion led to
discontinuities of the nuclear envelope and the emergence of
DNA segments uncovered by the nuclear lamina (Fig. 1a;
Supplementary Fig. 3a and Supplementary Movies 3,4,5).
Remarkably, these segments of DNA in PPP1R12A or PPP1CB-
depleted cells were not covered by any marker of the nuclear
envelope tested, including lamin A and B1, the lamina-associated
protein LAP2b, nuclear pore complex proteins and the inner
nuclear membrane protein SUN1. Time-lapse imaging revealed
that the nuclear envelope was highly dynamic and rapidly re-
formed over areas of uncovered chromatin (Supplementary
Movies 1,2). These results indicate a rupture of the nuclear
envelope. The expression of the chromatin and nuclear envelope
marker proteins necessary for time-lapse imaging (H2B-mCherry
and AcGFP-LAP2b, respectively) did not alter nuclear shape in
untreated cells or the nuclear morphology phenotype caused by
depletion of PPP1R12A (Supplementary Fig. 4a,b). The majority
of chromatin segments that were not covered by nuclear envelope
markers in myosin phosphatase-depleted cells remained con-
nected to the main nuclear mass through thin chromatin bridges
indicating that these segments were derived from a single nucleus
(Supplementary Fig. 3b). A minority of the extruded chromatin
segments was no longer connected to main nuclear body. The
nuclear integrity defects observed in PPP1R12A or PPP1CB-
depleted cells differ from previously described nuclear envelope
aberrations19,20 due to the presence of massive chromatin
extrusions, nuclear compression and bifurcation sites, and the
emergence of chromatin segments that are not covered by any
nuclear envelope marker tested.
Loss of PPP1R12A compromises the nuclear compartment.
The discontinuity of nuclear envelope markers around DNA
segments suggested that the nuclear compartment might be
compromised in cells lacking PPP1R12A or PPP1CB. Consistent
with this hypothesis, cells depleted of PPP1R12A showed a
threefold increase in the fraction of cells with cytoplasmic pro-
myelocytic leukemia protein (PML) aggregates, structures of 0.1
to 1 mm in diameter that normally reside in the nucleus and are
too large to pass through nuclear pores (Fig. 1c)21. To directly
interrogate the integrity of the nuclear compartment, we
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established a nuclear envelope barrier assay by co-expression of
GFP fused to a nuclear export signal (AcGFP-NES) to mark the
cytoplasm and mCherry fused to a nuclear localization signal
(mCherry-NLS) to mark the nucleoplasm. In control interphase
cells, the cytoplasmic and nuclear fluorescent marker proteins
remained in their respective compartments (Supplementary
Movies 6) (no exchange event recorded in 83 cells over 4 h).
In contrast, in cells depleted of PPP1R12A, we detected
nuclear envelope rupture events characterized by the sudden
efflux of mCherry-NLS into the cytoplasm coinciding with the
influx of AcGFP-NES into the nucleus (Fig. 1d; Supplementary
Movies 7) (56 exchange events recorded in 292 cells over 4 h;
average duration 15 min). During these events the intensity of
mCherry-NLS in the nucleus and cytoplasm approached similar
levels indicating free diffusion across the two compartments
(Fig. 1d). We conclude that the loss of myosin phosphatase
function causes rupture of the nuclear envelope, which leads
to the emergence of DNA segments uncovered by nuclear



















































































































































Figure 1 | Depletion of PPP1R12A and PPP1CB causes nuclear deformation and nuclear envelope rupture. (a–c) HeLa Kyoto cells transfected with
PPP1R12A or PPP1CB siRNA were fixed 56 h after transfection. (a) Cells were stained with the indicated nuclear envelope markers and DAPI (left panel).
Quantification of phenotype (top right panel). Immunoblot analysis of siRNA-transfected cells (bottom right panel). Abnormal nuclear shape (deformed)
and nuclear envelope discontinuity (ruptured) are quantified. Error bars, s.d. of three independent experiments (n4200 cells each). (b) PPP1R12A and
PPP1CB siRNA-transfected cells were stained with DAPI and nuclear circularity was calculated for each nucleus (left panel). Red bars show mean and s.d. of
three experiments. Representative nuclear shapes and their circularity indices are shown (right panel). Error bars, s.d. of three independent experiments
(n4100 nuclei each). (c) Localization of PML in PPP1R12A-depleted cells was analysed by immunofluorescence staining. The filled arrowheads indicate
cytoplasmic PML signals. Percentages obtained from three independent experiments (n4200 cells each). Mean of three experiments±s.e.m. is shown.
(d) Time-lapse microscopy of PPP1R12A-siRNA-transfected HeLa Kyoto cells transiently expressing AcGFP-NES and mCherry-NLS (left panel). Recording
was started 40 h after transfection (0 min). mCherry-NLS signal intensity in the nucleus and cytoplasm was quantified over time (right panel). The filled
arrowheads indicate nuclear rupture events characterized by the sudden efflux of mCherry-NLS from the nucleus into the cytoplasm. Graphs in a,b show
****Po0.0001 (a w2 test, b one-way ANOVA Tukey’s multiple comparison test). Scale bars, 10mm.
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Unrestrained contractility causes nuclear envelope rupture.
Next, we aimed at elucidating the molecular basis of PPP1R12A–
PPP1CB’s function in safeguarding nuclear morphology and
nuclear envelope integrity. Depletion of PPP1R12A did not
strongly alter the cellular protein levels of lamin A and lamin B1
(Supplementary Fig. 4c,d). Depletion of PPP1R12A did also not
induce apoptosis as judged by cytochrome c release from mito-
chondria and poly(ADP-ribose) polymerase cleavage
(Supplementary Fig. 5a,b). PPP1R12A-depleted cells were less
migratory than control counterparts indicating that disruption of
nuclear morphology is unlikely to be driven by cell migration-
associated processes (Supplementary Fig. 5c). Furthermore, fixed
and live cell analysis revealed that the appearance of DNA outside
the nuclear envelope was not the result of aberrant chromosome
partitioning during mitosis or of defective nuclear envelope
reformation during mitotic exit in PPP1R12A-depleted cells
(Supplementary Fig. 6a–c; Supplementary Movies 8 and 9).
Nuclei rather appeared to fragment shortly after the
completion of mitosis in the absence of PPP1R12A
(Supplementary Movies 9). PPP1R12A–PPP1CB has been
reported to control the activity of the mitotic kinase PLK1 by
dephosphorylating PLK1’s T-loop at T210 (ref. 22). However, we
did not observe a measurable increase in phosphoT210 PLK1
signal in HeLa cells depleted of either PPP1R12A or PPP1CB
(Supplementary Fig. 6d). These observations suggest that altera-
tions in the levels of lamin A and B1 proteins, the induction of
apoptosis, cell migration and mitosis-related aberrations are not
the culprits responsible for the striking nuclear integrity defects
observed upon the loss of PPP1R12A–PPP1CB phosphatase.
The highly dynamic movement of nuclei and nuclear envelope
indentations observed in cells depleted of PPP1R12A indicated
the possible involvement of cytoskeletal elements and forces
(Supplementary Movies 2,7 and 9). PPP1R12A–PPP1CB is
known to antagonize cellular actomyosin contractility by depho-
sphorylating myosin regulatory light chain MYL9 (MRLC)23.
MRLC is activated by phosphorylation of T18 and S19 at the
hands of ROCK kinases downstream of the GTPase RhoA9. This
raised the possibility that unrestrained contractility of actomyosin
could be responsible for the nuclear damage in cells lacking
PPP1R12A–PPP1CB phosphatase. Consistent with this
hypothesis, depletion of PPP1R12A lead to increased MRLC
phosphorylation (Fig. 2a; Supplementary Fig. 7a). Strikingly,
treatment with the myosin ATPase inhibitor blebbistatin24, the
ROCK inhibitor Y-27632 (ref. 25) and the RhoA inhibitor C3
toxin26 restored normal nuclear morphology, nuclear circularity
and the integrity of the nuclear envelope in cells depleted of
PPP1R12A and PPP1CB (Fig. 2b,c). In contrast, inhibition of
myosin light chain kinase (MYLK) by addition of ML-7 had no
effect (Fig. 2b). PPP1R12A-depleted cells treated with
blebbistatin, Y-27632 and C3 toxin remained attached to the
substratum demonstrating that the rescue of nuclear integrity was
not caused by excessive cell rounding or detachment
(Supplementary Fig. 7b). Co-depletion of ROCK1 and ROCK2
by RNAi or overexpression of a non-phosphorylatable version of
MRLC, MRLC TASA (T18A S19A), also potently rescued the
nuclear defects caused by the loss of myosin phosphatase (Fig. 3a;
Supplementary Fig. 7c,d). Conversely, expression of a phospho-
mimetic version of MRLC, MRLC TDSD (T18D S19D), was
sufficient to induce nuclear fragmentation and nuclear envelope
rupture in otherwise unperturbed cells (Fig. 3b; Supplementary
Fig. 7d). Removal of the ROCK inhibitor Y-27632 from
PPP1R12A-depleted cells in interphase caused nuclear
fragmentation without passage through mitosis (Supplementary
Fig. 8). This suggests that nuclear damage is not linked to defects
in nuclear envelope reassembly during mitotic exit but can be
triggered throughout interphase. We conclude that the nuclear
fragmentation and nuclear envelope rupture observed in
PPPR12A–PPP1CB-depleted cells is not caused by a structural
defect of the nuclear envelope but by damage inflicted by
unrestrained actomyosin contractility in interphase cells. Our
analyses suggest that MRLC phosphorylation by ROCK is the key
target of PPPR12A–PPP1CB phosphatase in safeguarding nuclear
integrity, and that increased levels of MRLC phosphorylation are
sufficient to drive nuclear dysmorphia.
Mechanistic insights into actomyosin-driven nuclear damage.
How does the actomyosin network deform and damage the
nucleus in cells lacking the PPPR12A–PPP1CB complex? We
excluded a major role of linker proteins connecting F-actin and
the nuclear envelope (SUN1, SUN2 and SYNE2)4 in transmitting
disruptive effects from the F-actin network to the nucleus
(Supplementary Fig. 9). Interestingly, both the expression of
active MRLC TDSD and PPP1R12A depletion led to the
formation of actomyosin bundles in close proximity to the
nucleus that bisected the main body of the nucleus and the
smaller extruded segments (Fig. 3b,c; Supplementary Fig. 10a–c).
Correlative light and electron microscopy and three-dimensional
reconstruction of myosin phosphatase-depleted cells revealed the
presence of actomyosin bundles on top of nuclear compression
regions proximal to nuclear envelope rupture sites (Fig. 3c;
Supplementary Fig. 10b,c). More than 80% of nuclear
compression and nuclear envelope rupture sites were associated
with F-actin in PPP1R12A-depleted cells (Supplementary
Fig. 10c). This suggests that cytoplasmic actomyosin bundles
could generate contractile forces that may squeeze the nucleus to
such an extent that the nuclear lamina ruptures. Consistent with
this hypothesis, genetic inactivation of lamin A in mouse
embryonic fibroblasts (LMNA / MEFs)19 rendered nuclear
integrity exquisitely sensitive to the effects of PPP1R12A
depletion (Fig. 4a; Supplementary Fig. 11). Thus, the rigidity
provided by lamin A protects the nuclear envelope from the
impact of actomyosin activity and possibly forces.
Enhancing actomyosin contractility through PPP1R12A or
PPP1CB depletion led to nuclear rupture in HeLa, MDA-MB-
231, A549, SiHa and HT1080 cancer cells but had little effect on
nuclear integrity in telomerase-immortalized hTERT RPE-1 cells
and BJ-5ta primary fibroblasts (Supplementary Fig. 12). Compar-
ison of primary vulval squamous cell carcinoma (VSCC) cells and
vulval carcinoma-associated fibroblasts (VCAF) isolated from the
same patient confirmed that depletion of PPP1R12A had a
stronger effect in cancer cells (Fig. 4b). These observations
suggest that transformed cells may be more amenable to force-
mediated deformation of the nucleus than normal cells, possibly
due to reduced nuclear stiffness in the former27.
Actomyosin is a determinant of nuclear shape and dynamics.
We observed that the nuclei of LMNA / cells were less cir-
cular than controls even in under basal conditions and that
nuclear circularity in these cells could be restored by addition of
blebbistatin (Fig. 4a). This suggested that actomyosin contractility
could be a major determinant of nuclear shape and drive nuclear
dysmorphia in cancer. Consistent with this hypothesis, suppres-
sing actomyosin activity by treatment with blebbistatin sig-
nificantly increased nuclear circularity in cancer cell lines of
different tissue origins, including the breast cancer cell line MDA-
MB-231 (Fig. 5a). These data indicate that the nuclear atypia
characteristic of many tumour cells is, at least in part, driven by
actomyosin activity.
To extend our observations beyond cell culture to an in vivo
setting, we generated MDA-MB-231 cells stably expressing H2B-
mCherry and AcGFP-LAP2b. Depletion of PPP1R12A in MDA-
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MB-231 cells cultured in vitro resulted in enhanced nuclear
deformation and nuclear envelope rupture that were suppressed
upon treatment with the ROCK inhibitor Y-27632
(Supplementary Fig. 13a). MDA-MB-231 cells stably expressing
H2B-mCherry and AcGFP-LAP2b were injected under the nipple
of nude mice. Once tumours had formed, intravital imaging was
used to monitor dynamic changes in nuclear morphology
(Fig. 5b,c). Nuclear morphologies were observed with a similar
circularity score in vivo (Supplementary Fig. 13b) as in vitro
(Fig. 5a). Importantly, regions of chromatin devoid of nuclear
envelope were observed to form and be resolved in some cells
in vivo (Fig. 5c; Supplementary Movie 10 and Supplementary
Fig. 14). To determine if actomyosin contractility was driving the
dynamic nuclear morphology, we treated tumours with the
ROCK inhibitor Y-27632 (Supplementary Movies 11 and 12).
The dynamic deformation of nuclei in xenografts was quantified
by measuring parameters of individual nuclei over time and then
calculating the variance of the values recorded for each nucleus
(Fig. 5d). A high variance indicates dynamically changing nuclear
morphology. ROCK inhibition reduced the variance of nuclear
perimeter, circularity and aspect ratio (Fig. 5d). In addition,
ROCK inhibition increased nuclear circularity and reduced the
nuclear perimeter in xenografts (Supplementary Fig. 13b). In line
with our in vitro observations, these data strongly suggest that
actomyosin contractility drives dynamic nuclear deformation and
possibly nuclear envelope rupture in vivo. Further, dynamic
nuclear deformation was not restricted to migratory cells, which
is consistent with our observation that PPP1R12A depletion
reduces migration in vitro (Supplementary Fig. 5c). Indeed, the
large number of non-migratory cancer cells, compared to
migratory cancer cells, meant that more dynamic nuclear
deformation events were observed in non-migratory cells in
imaged tumours (Supplementary Fig. 13c).
Unrestrained actomyosin activity drives genome instability.
Next, we investigated whether nuclear deformation and rupture
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Figure 2 | Actomyosin contractility drives nuclear deformation and rupture in PPP1R12A and PPP1CB-depleted cells. (a) HeLa Kyoto cells were
harvested 56 h after transfection with the indicated siRNA duplexes and analysed by quantitative immunoblotting. (b,c) HeLa Kyoto cells transfected with
non-targeting control, PPP1R12A or PPP1CB siRNA were fixed 56 h after transfection and processed for immunofluorescence analysis. (b) siRNA-
transfected cells were treated with 5 mM blebbistatin, 5mM Y-27632, 10mM ML-7, or 0.4mg ml 1 C3 toxin for 24 h before fixation. Representative
immunofluorescence images are shown in the top panel. Abnormal nuclear shape (deformed) and nuclear envelope discontinuity (ruptured) are quantified
in the bottom panel. Scale bar, 10 mm. (c) Quantification of nuclear circularity using the data from images acquired in b. Error bars, s.d. of three independent
experiments (n4200 cells each) (b,c). Graph shows ****Po0.0001 (one-way ANOVA Tukey’s multiple comparison test).
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instability. Depletion of PPP1R12A resulted in an increase in the
signal intensity of the DNA damage markers g-H2AX and 53BP1
in interphase nuclei (Fig. 6a,b). The magnitude of the g-H2AX
increase observed in PPP1R12A-depleted cells was similar to the
one caused by treatment with the DNA polymerase inhibitor
aphidicolin (Fig. 6a). Importantly, nuclear g-H2AX signals in
PPP1R12A-depleted cells were restored to close to baseline levels
by addition of the ROCK inhibitor Y-27632 (Fig. 6a). Nucleotide
analogue labelling experiments demonstrated that g-H2AX
induction occurred with a similar incidence in both replicating
and non-replicating cells after depletion of PPP1R12A
(Supplementary Fig. 15). This suggests that the DNA damage
inflicted by unrestrained actomyosin contractility is not restricted
to S phase but may occur throughout interphase. While DNA
damage marked by g-H2AX foci was distributed throughout the
nucleus in most PPP1R12A-depleted cells (Fig. 6a), we observed
striking examples in which the g-H2AX signal was highly enri-
ched and locally concentrated in chromatin segments that were
protruding from the main nucleus and that lacked nuclear
envelope markers (Fig. 6c). This suggests that nuclear deforma-
tion and nuclear envelope rupture could result in localized DNA
damage consistent with previous observations in micronuclei that
arose through mitotic segregation errors28,29.
Finally, to probe the consequences of the DNA damage
observed in interphase, we used mitotic chromosome spreading.
To allow mitotic entry of cells with damaged chromosomes,
siRNA-transfected cells were treated with the DNA damage
checkpoint inhibitor caffeine. Mitotic chromosome spreads
revealed that depletion of PPP1R12A led to an increased
frequency of gross structural chromosome aberration, such as
sister chromatid breaks and hypocondensation of chromosome
segments (Fig. 7). In extreme cases, the majority of chromosomes
of a karyotype were shattered in cells lacking PPP1R12A.
Inhibition of ROCK strongly suppressed the emergence of
chromosomal aberrations in cells lacking PPP1R12A (Fig. 7).
Remarkably, these analyses describe a genome instability
phenotype that is dependent on actomyosin contractility. Our
data suggest that unrestrained actomyosin activity causes physical
stress upon the nucleus driving nuclear deformation, nuclear
envelope rupture and genome instability.
Discussion
Altered nuclear morphology is a recurring feature of tumour
histology, yet the molecular mechanisms that perturb nuclear
shape are not well understood. Perturbation of the nuclear lamina
has been reported to lead to altered nuclear morphology in
several studies30,31. The shape variation and increased
deformability of leukocyte nuclei correlates with lower lamin
expression32. However, nuclear morphology is not just dependent
on the physical properties of the nuclear envelope, but is also
critically influenced by the forces exerted on the nucleus. We
demonstrate that actomyosin contractility is a major determinant
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Figure 3 | Deregulation of MRLC phosphorylation causes ectopic actomyosin fibre formation and nuclear deformation. (a) HeLa Kyoto cells were
transduced with lentiviral particles encoding EGFP, MRLC-EGFP wildtype or MRCL-EGFP T18A S19A (TASA). 15 h after infection, cells were transfected
with the indicated siRNA duplexes and processed for immunofluorescence analysis 56 h after transfection. Only EGFP signal-positive cells were scored.
Representative cell images (left panel) and quantification of nuclear phenotype (right panel) are shown. (b) HeLa Kyoto cells were infected with lentiviral
particles encoding MRLC-EGFP wildtype or a T18D S19D mutant (TDSD) and processed for immunofluorescence analysis 56 h after infection. Only
EGFP signal-positive cells were scored. Representative cell images (left panel) and quantification of nuclear phenotype (right panel) are shown.
(c) PPP1R12A-depleted cells were fixed and stained for with anti-lamin B1 antibodies, DAPI and fluorophore-conjugated phalloidin. Cells were scanned in
0.1mm sections using confocal laser scanning microscopy. The 3D image was reconstituted and rendered using Imaris software. Error bars, s.d. of three
independent experiments (n4200 cells each) (a,b). Scale bars, 10mm.
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Inhibition of actomyosin contractility increases nuclear circularity
in a panel of cancer cell lines. If deregulated by loss of the myosin
phosphatase PPP1R12A–PPP1CB, unrestrained actomyosin
activity and possibly actomyosin-dependent forces have
detrimental effects on nuclear integrity including nuclear
fragmentation, nuclear envelope rupture, loss of the nuclear
compartment barrier and genome instability. The corollary of this
conclusion is that myosin phosphatase prevents the cell nucleus
and the genome from being attacked by actomyosin contractility.
Our results suggest that thick cytoplasmic actomyosin fibres that
are formed upon loss of myosin phosphatase locally compress the
nucleus leading to nuclear envelope rupture and chromatin
protrusions. This mechanism does not require protein complexes
that link cytoplasmic cytoskeletal filaments to the nuclear
envelope (such as LINC). Our data are consistent with the
notion that the stiffness of the nuclear envelope conferred by
LMNA moderates the impact of actomyosin activity on nuclear
morphology and integrity. Unrestrained actomyosin activity had
more pronounced effects on nuclear integrity in cancer cells than
in telomerase-immortalized or primary cells. This observation
could be explained by the emerging view that the nuclei of
malignant cells are softer than that of normal cells27. Our work
identifies the RhoA–ROCK axis, which is frequently deregulated
in tumours33, as the pathway driving nuclear damage through
promoting the phosphorylation of myosin regulatory light chain.
A related actomyosin-dependent mechanism might be utilized
during apoptotic nuclear disintegration when ROCK cleavage at
the hands of caspases causes enhanced contractility34. In the
future, it will be important to interrogate whether oncogenic
driver pathways that impact on Rho family GTPases alter nuclear
shape and genome stability via the actomyosin cytoskeleton.
Actomyosin fibres and contractility influence both cell shape
and nuclear shape35,36. Since our study does not assess cell shape
directly, we cannot formerly exclude the possibility that
deregulating actomyosin activity in myosin phosphatase-
depleted cells or contractility inhibitor-treated cells causes
nuclear shape changes indirectly via influencing cell shape.
However, three observations strongly support the conclusion that
actomyosin fibres directly impact the shape and integrity of nuclei
in cells lacking myosin phosphatase in our study. First, most
nuclear deformation and rupture sites are associated with
actomyosin fibres in cells lacking myosin phosphatase. Second,
myosin phosphatase-depleted cells remain attached to the
substratum when nuclear integrity is restored upon treatment
with contractility regulators. Lastly, it is difficult explain the
dramatic nuclear deformation and multiple nuclear envelope
rupture phenotypes observed in myosin phosphatase-depleted
cells by invoking changes in cell shape only.
Physical forces and actomyosin structures have an impact on
nuclear morphology and integrity. Forces acting on the nucleus of
cells migrating through small gaps can lead to compression and
disruption of the nuclear envelope as well as to DNA damage37,38.
A perinuclear actin system stimulated by the formin protein
FMN2 was recently shown to protect nuclear integrity during
extravasation and metastasis39. Actin can also have disruptive
effects on the cell nucleus. The combined inactivation of two
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Figure 4 | Impact of PPP1R12A depletion on nuclear morphology in LMNA / and patient-derived cells. (a) LMNAþ /þ and  / mouse
embryonic fibroblasts were transfected with the indicated siRNA duplexes and stained with DAPI 56 h after transfection. Cells were exposed to DMSO
solvent control or 5mM blebbistatin for 24 h before fixation. Representative images (left panel) and quantification of nuclear circularity (right panel) are
shown. Error bars, s.d. of three independent experiments (n4100 nuclei each). Scale bar, 10mm. (b) Vulval squamous cell carcinoma cells (VSCC10) and
vulval cancer-associated fibroblasts (VCAF10) primary cells were transfected with the indicated siRNAs for 48 h. Representative cell images (left panel)
and quantification of nuclear phenotype (right panel) are shown (VSCC10 siControl; n¼ 100, siPPP1R12A; n¼82, VCAF10 siControl; n¼ 89, siPPP1R12A;
n¼ 78 cells per condition). Scale bar, 20mm. Graphs show ****Po0.0001 (a unpaired t test; b w2 test).
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F-actin severing proteins has been shown to promote the ectopic
formation of stress fibres that cause nuclear deformation in
epithelial cells40. Recent findings in cultured human cells also
suggest that actin-based nucleus confinement in conjunction with
LINC complexes can promote nuclear envelope rupture41. Our
work on PPP1R12A–PPP1CB and the aforementioned studies
suggests that nuclear deformation can occur in an actomyosin
force-dependent manner that is not coupled to cell migration.
Indeed, the absolute number of dynamic nuclear deformation
events observed in non-motile cells was higher than in motile
cells in the imaged tumour. The mechanism we describe is likely
to be relevant for the control of nuclear shape and genome
integrity in tumours even before the onset of invasion.
One of the striking findings emerging from our work is that
unrestrained actomyosin activity can promote genome instability.
PPP1R12A-depleted cells show increased g-H2AX signals and
53BP1 foci, indicative for underlying DNA damage such as DNA
double strand breaks. Importantly, the increase in g-H2AX levels
observed in PPP1R12A-depleted cells was dependent on
actomyosin contractility. On the basis of nucleotide analogue
incorporation experiments, the DNA damage inflicted by
actomyosin contractility was not restricted replicating cells but
likely occurs throughout interphase. The fact that the DNA
damage signals were not aligned with actomyosin fibres bisecting
the nucleus in most cells suggests that the impact of physical


























































































































Figure 5 | Actomyosin contractility is a determinant of nuclear shape and dynamics. (a) Cancer cell lines derived from different tissues were treated with
5 mM blebbistatin for 24 h, fixed and stained with DAPI. Quantification of nuclear circularity (left panel) and representative images of the breast cancer cells
line MDA-MB-231 (right panel) are shown. Error bars, s.d. of three independent experiments (n4100 nuclei each). Scale bar, 10mm. (b) Intravital imaging
of an MDA-MB-231 xenograft tumour expressing AcGFP-LAP2b and H2B-mCherry. Collagen is shown in blue. Scale bar, 20mm. (c) Intravital time-lapse
series of an MDA-MB-231 tumour expressing AcGFP-LAP2b and H2B-mCherry. The arrowheads indicate a potential nuclear envelope rupture event.
Images represent fields of 30 mm 30mm. Scale bar, 10 mm. (d) Quantification of nuclear perimeter, circularity and aspect ratio variance over time from
intravital MDA-MB-231 imaging movies (c). Variance values for individual cells of control and Y-27632-treated tumours are plotted (control; n¼ 32,
Y-27632; n¼ 37 cells each). Graph shows ***P¼0.0002, ****Po0.0001 (unpaired t test).
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loss of the nuclear compartment resulting in the efflux and
dilution of DNA repair and metabolism factors may be driving
genome instability. This hypothesis is supported by studies
showing that nuclear envelope collapse is linked to genome
instability and chromothripsis in micronuclei28,29. Whether
actomyosin contractility-inflicted nuclear fragmentation and
nuclear envelope rupture can result in the shattering and
erroneous reassembly of one or a few chromosomes that is























































































































Figure 6 | Induction of DNA damage markers by unrestrained actomyosin activity. (a,b) HeLa Kyoto cells transfected with non-targeting control
(siControl) or PPP1R12A-siRNA duplexes were processed for immunofluorescence staining 56 h after transfection. (a) Cells were treated with 5 mM
Y-27632 or 400 nM aphidicolin for 24 h before fixation. Cells were stained with an anti-g-H2AX antibody and DAPI. Representative images (left panel) and
the quantification of g-H2AX nuclear signal intensity (right panel) are shown. Mean nuclear intensities of individual cells are plotted. (b) Cells were stained
with an anti-53BP1 antibody and DAPI. Representative images (left panel) and quantification of 53BP1-positive cells (right panel) are shown. Cells with
more than five 53BP1 foci were scored as 53BP1-positive cells. (c) HeLa cells transfected with siPPP1R12A were stained with anti-lamin B1, g-H2AX and
DAPI. Error bars, s.d. of three independent experiments (n4100 nuclei each) (a and b). Graph shows ****Po0.0001 (a one-way ANOVA Tukey’s multiple





























Figure 7 | Loss of PPP1R12A causes contractility-dependent gross chromosomal aberrations. Cells were treated with 5 mM Y-27632 for 24 h before
fixation. Mitotic cells were collected by shake-off after the treatment with 330 nM nocodazole and 2 mM caffeine for 5 h. Mitotic chromosomes were
analysed by chromosome spreading and Giemsa staining. Example karyotypes (left panel) and quantification of karyotypes with abnormal chromosomes
(right panel) are shown. Error bars, s.d. of three independent experiments (n4300 spreads each). Graph shows ***P¼0.0001, ****Po0.0001 (one-way
ANOVA Tukey’s multiple comparison test). Scale bars, 10mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms16013 ARTICLE
NATURE COMMUNICATIONS | 8:16013 | DOI: 10.1038/ncomms16013 | www.nature.com/naturecommunications 9
characteristic of chromothripsis42 remains to be tested. The
chromosomal aberrations observed in PPP1R12A-depleted cells
provide support for this hypothesis. Furthermore, although most
extruded chromatin segments remain connected to the main
nuclear body in PPP1R12A-depleted cells, the highly localized
g-H2AX signal observed in extruded chromatin regions lacking
nuclear envelope markers in a subset of cells are reminiscent of
the situation observed in micronuclei29. The essential
DNA damage kinase ATR was recently found to relocalize to
nuclear membranes upon mechanical stress where it could
modulate nuclear envelope plasticity and chromatin association
to the nuclear envelope29. It will be interesting to interrogate
the subcellular distribution of ATR as well as the consequences
of selective ATR inhibition in cells depleted of myosin
phosphatase.
We found that PPP1R12A depletion leads to frequent and
rapid loss of the nuclear compartment involving efflux bursts of
soluble nuclear proteins into the cytoplasm. The transient nature
of these events (average duration 15 min) suggests that emerging
gaps in the nuclear envelope are resealed quickly and efficiently.
Using correlative light and electron microscopy, we observed that
chromatin regions that are not covered by the nuclear envelope
marker LAP2 are surrounded by a membranous structure
(Supplementary Fig. 10b). Co-labelling experiments with the
translocation pore marker SEC61B suggest that these membranes
are derived from the rough endoplasmatic reticulum or from a
section of the nuclear membrane that was left behind following
rupture the nuclear lamina (Supplementary Fig. 10d). This raises
the possibility that the rapid resealing of nuclear leaks may
involve the association of chromatin with rough endoplasmatic
reticulum membranes prior to the re-establishment of a nuclear
lamina. Myosin phosphatase-depleted cells have the potential to
serve as a useful model for studying the mechanisms underlying
the sealing and repair of nuclear envelope rupture events in the
future. Recent reports implicated the ESCRT-III membrane
fission complex in sealing nuclear envelope rupture events upon
nuclear confinement37,38. Whether ESCRT-III is also involved in
repairing actomyosin-inflicted nuclear envelope rupture events
remains to be tested.
To conclude, we demonstrate that nuclear dysmorphia of
cancer cells and nuclear shape in general are controlled by the
balance of opposing ROCK and PPP1R12A–PPP1CB
phosphatase activities on myosin regulatory light chain. Hyper-
activated and phosphorylated myosin light chain can generate
sufficient actomyosin contractility and possibly forces to deform,
and even break the nuclear envelope triggering genome
instability.
Methods
Phosphatase siRNA screen. A phosphatase siRNA library targeting 264 genes
was obtained in 96 well format with pools of four individual siGENOME siRNA
duplexes per well from Dharmacon (see Supplementary Data 1 for list of genes).
HeLa Kyoto cells were transfected with siRNA at 30 nM using DharmaFECT 1
(Dharmacon). Cells were cultured for 72 h and fixed in –20 C methanol. Fixed
cells were stained using an a-tubulin antibody and 40 ,6-diamidino-2-phenylindole
(DAPI). Images were acquired on a Zeiss Axio Imager M2 microscope using a
Plan-Neofluar  40/1.3 numerical aperture (NA) oil objective lens (Zeiss) equip-
ped with an ORCA-ER camera (Hamamatsu) and controlled by Volocity 6.0.1
software (Perkin Elmer). Images were subsequently scored for the fraction of nuclei
with abnormal morphology (n4100 cells).
Reagents. Target, supplier and catalogue number of the siRNA pools used for the
phosphatase siRNA screen are listed in Supplementary Data 1. Antibodies,
other siRNA duplexes and chemicals/reagents used throughout this study are
listed in Supplementary Tables 1, 2 and 3, respectively. Details including
suppliers, catalogue numbers and antibody dilutions are listed in the three
tables.
Antibodies. Primary antibodies used for immunoblotting and immuno-
fluorescence microscopy were rabbit anti-PPP1R12A (Santa Cruz Biotechnology
sc-25618; immunoblotting 1:500), mouse anti-PPP1CB (Abcam ab53315; immu-
noblotting 1:50,000), mouse anti-lamin A (Abcam ab8980; immunofluorescence
1:1,000), mouse anti-lamin A (Cell Signaling Technology 4777; immunoblotting
1:2,000), rabbit anti-lamin B1 (Abcam ab16048; immunoblotting 1:5,000, immu-
nofluorescence 1:1,000), mouse anti-LAP2 (BD Biosciences 611000; immuno-
fluorescence 1:1,000), mouse anti-NPC (Abcam ab50008, immunofluorescence
1:500), rabbit anti-SUN1 (Novus Biologicals NBP1-87396, immunofluorescence
1:400), rabbit anti-SUN2 (Abcam ab124916, immunofluorescence 1:100), mouse
anti-SYNE2 (Thermo Scientific K20-478-5, immunofluorescence 1:1,000), mouse
anti-PML (Abcam ab96051, immunofluorescence 1:500), mouse anti-ROCK1 (BD
Biosciences 611137; immunoblotting 1:250), rabbit anti-ROCK2 (Santa Cruz Bio-
technology sc-5561; immunoblotting 1:1,000), mouse anti-PLK1 (Santa Cruz
Biotechnology sc-17783; immunoblotting 1:2,000), rabbit anti-PLK1 pT210 (Cell
Signaling Tech 5472; immunoblotting 1:1,000), mouse anti-cyclin B (Santa Cruz
Biotechnology sc-245; immunoblotting 1:2,000), rabbit anti-MRLC pS19 (Cell
Signaling Tech 3671; immunoblotting 1:50, immunofluorescence 1:1,000), mouse
anti-aurora B (BD Biosciences 611082; immunofluorescence 1:500), mouse anti-g-
H2AX (Millipore 05-636; immunofluorescence 1:600), mouse anti-cytochrome c
(Life Technology 33-8200; immunofluorescence 1:25), mouse anti-GFP (Roche
11814460001; immunoblotting 1:1,000, immunofluorescence 1:1,000), mouse anti-
GAPDH (Abcam ab8245; immunoblotting 1:40,000), mouse anti-AcGFP (Clontech
632381; immunofluorescence 1:1,000), rabbit anti-53BP1 (Novus Biologicals
NB305-305; immunofluorescence 1:1,200), rabbit anti-cleaved PARP (Cell Signal-
ling Tech 5625; immunofluorescence 1:400), mouse anti-a-tubulin (Sigma T6024;
immunoblotting 1:20,000), rabbit anti--tubulin (Cell Signalling Tech 5346;
immunoblotting 1:2,000), phalloidin Alexa Fluor 488 (Life Technology A12379;
immunofluorescence 1:500) and phalloidin Alexa Fluor 564 (Life Technology
A12380; immunofluorescence 1:500).
HRP-conjugated secondary antibodies (GE Healthcare) were used to detect
proteins on immunoblotting using chemiluminescence. For quantitative
fluorescence immunoblotting, secondary antibodies conjugated to IRDye 680 and
IRDye 800 (LI-COR; 1:5,000) were used for detection. Cross-adsorbed secondary
antibodies conjugated to Alexa 488, Alexa 594, Alexa 568 or Alexa 647 (Life
technology; 1:500) were used for immunofluorescence detection. Antibody
information is also listed in Supplementary Table 1.
Plasmids. PPP1R12A (NM_002480) and PPP1CB (NM_002709) were inserted
into pIRESpuro3-FLAc (FL denotes FLAG epitope; Ac denotes Aequorea coer-
ulescens green fluorescent protein 1 (AcGFP))43. To create siRNA-resistant alleles,
the PPP1R12A sequence TTCCATTTCT was changed to CAGCATCAGC, and the
PPP1CB sequence TGGTGTTTC was changed to CGGCGTGAG by introducing
synonymous mutations. The resulting plasmids are named pIRESpuro3-
PPP1R12Ar-FLAc and pIRESpuro3-PPP1CBr-FLAc, respectively. Rat LAP2b
(amino acids 244-453) was inserted into pIRESpuro3-AcFL44 to obtain
pIRESpuro3-AcFL-LAP2b. SEC61B (NM_006808.2) was inserted into
pIRESpuro3-AcFL to obtain pIRESpuro3-AcFL-SEC61B. pIRESpuro3-AcGFP-NES
was constructed by fusing the sequence encoding the nuclear export signal (NES)
of HIV-1 Rev (amino acids PLQLPPLQRLTLN) to AcGFP. pIRESneo3-mCherry-
NLS was constructed by fusing the sequence encoding the nuclear localization
signal (NLS) of SV40 large T antigen (amino acids GGPKKKRKV) to mCherry.
pLVXpuro-MRLC-EGFP WT, TASA (T18A S19A) and TDSD (T18D S19D) were
constructed by inserting rat MRLC (MYL12B NP_059039.2)-EGFP with or without
the indicated point mutations into pLVXpuro (Takara, Clontech).
Cell culture and transfection. Cell lines used in this study were cultured in
DMEM supplemented with 10% fetal bovine serum. HeLa Kyoto cells were
obtained from the Research Institute of Molecular Pathology (Vienna, Austria).
The cell lines A549, DLD-1, HT1080, MCF-7 and MDA-MB-231 were obtained
from HPA Cultures (formerly known as ECACC). The cell lines BJ-5ta, hTERT-
RPE1, SiHa and U-2 OS were obtained from ATCC. HeLa Kyoto, MDA-MB-231,
A549, SiHa, U-2 OS, MCF-7, DLD-1, hTERT RPE-1 and BJ-5ta cell lines were
verified using STR profiling. All cell lines were tested negatively for mycoplasma
contamination. Plasmid transfection was performed using FuGENE 6 (Roche). For
siRNA transfection, cells were cultured for 15 h or more before transfection. siRNA
duplexes (listed in Supplementary Table 2) were transfected at 30 nM using
DharmaFECT 1. Culture medium was changed 24 h after transfection. Cells were
usually cultured for 56 h after siRNA transfection before performing analyses.
Immortalized LMNAþ /þ and  / mouse embryonic fibroblasts were kindly
provided by Colin Stewart19. Vulval squamous cell carcinoma (VSCC10) and
vulval carcinoma-associated fibroblast (VCAF10) were isolated from a vulval
squamous cell carcinoma patient at Barts Hospital and the London NHS Trust
following Research Ethics Committee approval 15/EE/0151. Informed patient
consent was obtained.
Establishment of stable cell lines. To establish HeLa Kyoto cells stably expres-
sing PPP1R12A-FLAc and PPP1CB-FLAc, cells were transfected with pIRESpuro3-
PPP1R12Ar-FLAc and pIRESpuro3-PPP1CBr-FLAc, respectively, and selected in
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medium supplemented with 0.3 mg ml 1 puromycin (Sigma). HeLa Kyoto cells
stably expressing AcFL-LAP2b were established by transfection with pIRESpuro3-
AcFL-LAP2b followed by selection in medium supplemented with 0.3 mg ml 1
puromycin. HeLa Kyoto H2B-mCherry cells44 were transfected with pIRESpuro3-
AcFL-LAP2b and selected in medium supplemented with 0.3 mg ml 1 puromycin
and 400mg ml 1 G418 (GIBCO) to establish HeLa Kyoto cells stably expressing
AcGFP-LAP2b and H2B-mCherry. To establish MDA-MB-231 cells stably
expressing AcGFP-LAP2b and H2B-mCherry, MDA-MB-231 cells were first
transfected with pIRESpuro3-AcFL-LAP2b and selected in medium supplemented
with 0.25 mg ml 1 puromycin. AcGFP-positive cells were then used for
transfection with pIRESneo3-H2B-mCherry and selected in medium supplemented
with 400 mg ml 1 G418.
Lentivirus production and infection. HEK293FT cells were co-transfected with
pLVXpuro-MRLC-EGFP (WT, TASA or TDSD) or pLVXpuro-EGFP and the 2nd
generation packaging system plasmids psPAX2 (Addgene, 12260) and pMD2.G
(Addgene, 12259) using Lipofectamine 2000 (Invitrogen). Viral particles were
collected at 24 and 48 h after transfection. HeLa Kyoto cells were infected with
lentiviral particles in the presence of 8 mg ml 1 polybrene (Sigma).
Immunoblotting. Cells were lysed in Laemmli buffer. Extracts were incubated at
95 C for 5 min followed by brief sonication. The protein concentration in extracts
was measured using the Bradford protein assay reagent (Bio-Rad). Samples were
subjected to SDS-PAGE, transferred to polyvinylidene difluoride membranes.
Membranes were probed with primary antibodies and subsequently with secondary
antibodies conjugated to horseradish peroxidase. Protein bands were detected by
using ECL system (GE Healthcare). For quantitative immunoblotting, secondary
antibodies conjugated to IRDye 800CW and IRDye 680RD (LI-COR) were used.
Protein band intensity was analysed using Odyssey (LI-COR). Full-sized immu-
noblots are shown in Supplementary Fig. 16.
Immunofluorescence microscopy. HeLa Kyoto cells were fixed with 4% for-
maldehyde at room temperature (RT) for 20 min or in methanol at  20 C
overnight and processed for immunofluorescence microscopy (IF) as descri-
bed45,46. For 53BP1 staining, cells were treated with pre-extraction buffer (10 mM
Pipes, pH 7, 100 mM NaCl, 300 mM sucrose, 1.5 mM MgCl2, 5 mM EDTA and
0.5% Triton X-100) for 5 min on ice, then fixed with 4% formaldehyde for 20 min
at RT. Primary antibodies used are listed in Supplementary Table 1. Alexa
fluorophore-conjugated secondary antibodies were used for detection. DNA was
stained using DAPI. Images were acquired using an Olympus FV1000D
(InvertedMicroscopeIX81) confocal laser scanning microscope equipped with a
PlanApoN  60/1.40 NA Oil Sc objective lens controlled by FV10-ASW software.
For visual inspection and scoring a Zeiss Axio Imager M1 microscope using Plan
Neofluor  40/1.3 oil objective lens (Zeiss) equipped with an ORCA-ER
camera (Hamamatsu) and controlled by Volocity 5.5.1 software (Improvision) was
used.
Statistical tests. P values were calculated using the paired t test, one-way
ANOVA Tukey’s multiple comparison tests and the w2 test of Prism Graphpad
software.
Measurement of nuclear circularity. Cells were fixed in with 4% formaldehyde
and stained with DAPI. Images of nuclei were acquired using an Olympus
FV1000D laser scanning confocal microscope. Acquired nuclear images were
analysed using the circularity function of Fiji software (https://fiji.sc)47 and
employing the formula: circularity¼ 4p(area/perimeter2).
EdU labelling. HeLa Kyoto cells were transfected with siRNA and cultured for
54 h. Cells were treated with 10 mM EdU (Click-iT Plus EdU Imaging Kit, Mole-
cular Probes) for 2 h before fixation. Incorporated EdU was detected according to
the instructions of the Click-iT Plus EdU Imaging Kit. After EdU detection, cells
were processed for g-H2AX and DAPI staining.
Live cell imaging. HeLa Kyoto cells stably expressing AcGFP-LAP2b and H2B-
mCherry were transfected with siRNA and cultured for 50 h before recording. Prior
to start of recording, the culture medium was changed to phenol-red free and CO2
independent medium (Invitrogen). Images were acquired as 4 z-planes 3 mm apart
every 3 min at 37 C using a Nikon TE2000 microscope equipped with a Plan Fluor
 60/1.4 DIC H Lens (Nikon), a PerkinElmer ERS Spinning disk system, a Digital
CCD C4742-80-12AG camera (Hamamatsu), and controlled by Volocity 6.0.1
software. Cell images were projected with z-stacks and analysed by ImageJ. For
analysis of cell migration, MDA-MB-231 cells were transfected with either control
or PPP1R12A-siRNA using Lipofectamine 2000 (Invitrogen). The following day
the cells were trypsinized and seeded in CO2 independent media (Invitrogen) in 24
well MatTek dishes (MatTek Corporation). Six to eight hours after seeding the cells
were imaged for 20 h using phase contrast microscopy using an adapted Zeiss
LSM510 microscope. Cell tracking was performed using the Manual Tracking
plugin in Fiji software.
Nuclear envelope barrier assay. Hela Kyoto cells were transiently transfected
with pIRESneo3-mCherry-NLS and pIRESpuro3-AcGFP-NES using FuGENE6.
After 6 h, non-targeting control or PPP1R12A-siRNA was transfected using
DharmaFECT 1. Time-lapse movies were performed 40 h after siRNA transfection.
Prior to the start of recording, the culture medium was changed to phenol-red free
and CO2 independent medium (Invitrogen). Images were acquired as 3 z-planes
2 mm apart every 2 min at 37 C using a Nikon TE2000 microscope equipped with a
Plan Fluor  60/1.4 DIC H Lens (Nikon), a PerkinElmer ERS Spinning disk
system, a Digital CCD C4742-80-12AG camera (Hamamatsu), and controlled by
Volocity 6.0.1 software. In each experiment, the number of cells and rupture events
were quantified. Nuclear envelope rupture events were defined as the sudden efflux
of mCherry-NLS into the cytoplasm and the sudden influx of AcGFP-NES into the
nucleus without mitotic entry. Duration of each event was calculated as the time
from marker influx/efflux until the mCherry-NLS began to accumulate in the
nucleus again. To quantify mCherry-NLS signals over time, mean mCherry-NLS
pixel intensity was measured by averaging four small circular regions manually
placed in the nucleus or in the cytoplasm of a cell using ImageJ (https://ima-
gej.nih.gov/ij/).
Nuclear envelope reformation assay. Hela Kyoto cells stably expressing AcGFP-
LAP2 were transiently transfected with pIRESneo3-mCherry-NLS using X-tre-
meGENE9. After 6 h, non-targeting control or PPP1R12A-siRNA was transfected
using DharmaFECT 1. 24 h after plasmid transfection, cells were treated with 2 mM
thymidine for 20 h, released for 6 h, arrested in mitosis with 50 ng ml 1 nocoda-
zole for 4 h. Subsequently cells were arrested in metaphase by addition of 10 mM
MG132 for 2 h. Cells were released into anaphase by washing with CO2 inde-
pendent medium (Invitrogen) and recorded. Images were acquired as 4 z-planes
4 mm apart every 5 min at 37 C using an Olympus FV1000D with a PlanApoN
 60/1.40 NA Oil Sc objective lens controlled by FV10-ASW software. Cell images
were projected with z-stacks and analysed by ImageJ. Timing of nuclear envelope
reformation was analysed by ImageJ and defined by the accumulation of mCherry-
NLS signal in a region surrounded by AcGFP-LAP2b.
3D reconstruction of cell images. HeLa Kyoto cells transfected with siRNA were
grown in LabTek chambered coverglass (Nunc) and processed for immuno-
fluorescence staining as described above. Cell images were acquired using an
Olympus FV1000D with a PlanApoN  60/1.40 NA Oil Sc objective lens con-
trolled by FV10-ASW software. Z-stacks were acquired at 0.1 mm step size across
the entire cell volume. 3D images were reconstructed and rendered using Imaris
software ver.6.4 (Bitplane).
Correlative light and electron microscopy. HeLa Kyoto cells expressing AcFL-
LAP2 and H2B-mCherry were transfected with control or PPP1R12A-siRNA and
cultured for 56 h. Cells were incubated with 2 mM SiR-actin for 2 h and then fixed
in 4% PFA/2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 15 min.
After fluorescence imaging, coverslips were processed using the Ellisman NCMIR
protocol; post-fixed in 2% osmium tetroxide/1.5% potassium ferrocyanide for 1 h,
on ice, then incubated in 1% weight per volume thiocarbohydrazide for 20 min
before a second staining with 2% osmium tetroxide, and then incubated overnight
in 1% aqueous uranyl acetate at 4 C. Following this, the cells were stained with
Walton’s lead aspartate for 30 min at 60 C. Cells were dehydrated through an
ethanol series on ice, and incubated in a 1:1 propylene oxide/Durcupan resin
mixture. Finally, the coverslips were embedded in Durcupan resin according to the
manufacturer’s instructions (TAAB Laboratories Equipment) and sectioned
(70 nm). Images were acquired using a Tecnai Spirit Biotwin (FEI Company,
Eindhoven, Netherlands) transmission electron microscope. Light and electron
microscopy overlays were generated using the TurboReg plugin of Fiji software,
with an affine transformation. Final adjustment was done by eye in Illustrator
CS5.1.
Intravital imaging. Intravital imaging was performed under permission granted in
UK Home Office licence PPL70/8380 following approval by the London Research
Institute ethical review panel. Briefly, one million MDA-MB-231 cells stably
expressing AcGFP-LAP2b and H2B-mCherry were injected in 20% Matrigel (BD
Bioscience) under the fourth nipple of ICRF Nu/Nu mice. Intravital imaging was
performed when tumours were between 5 and 12 mm in diameter. Mice were
anaesthetized using isofluorane in oxygen before a small incision was made to
expose the tumour margin. The mouse with the exposed tumour was then placed
on an inverted laser scanning microscopy (Zeiss LSM 780) and viewed through a
coverglass with a rubber ring to help stabilise the tumour against the breathing of
the mouse. A small volume of warm PBS (GIBCO) was placed in the ring to
prevent the tumour from drying. The tumour was maintained at physiological
temperature by a combination of a thermostatically controlled heated stage and
blanket over the tumour. A Ti-Sapphire laser tuned between 820 and 850 nm was
used for second harmonic imaging of collagen fibres. Single photon excitation was
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performed on AcGFP and mCherry using 488 and 561 nm lasers. Images were
acquired every 60 s (unless explicitly stated otherwise) for 30–40 min. Imaging was
performed within 20–80 mm of the tumour margin. For Y-27362 treatment, the
tumour was topically bathed in 50 mM Y-27632 within the rubber ring used for
imaging. 30 min was allowed to enable diffusion of Y-27632 into the tumour
margin. As before, imaging was performed within 20–80 mm of the tumour margin.
Analysis was performed using Fiji software. The nuclear morphology of individual
cells was traced at five intervals within the time-lapse data set (typically 7 or 8 min
apart). At each time point the perimeter, sphericity and aspect ratio were measured.
Both the average and the variance of these measurements at the five time points
were calculated for each cell.
c-H2AX quantification. HeLa cells transfected with siRNA duplexes or treated
with aphidicolin were fixed with 4% PFA. Cells were stained using DAPI and
g-H2AX antibodies. The intensity of nuclear g-H2AX for each cell was measured
by Fiji software. Individual cell data were normalized to the mean signal intensity
of cells transfected with control siRNA.
Chromosome spreading. To facilitate the analysis of structural chromosome
aberrations, HeLa cells were incubated for 5 h in medium containing 330 nM
nocodazole (Sigma) and 2 mM caffeine. Mitotic HeLa cells were swelled in a
hypotonic solution (DMEM:deionized water at 1:2 ratio) for 6 min at RT. Subse-
quently, cells were fixed with Carnoy’s buffer (freshly made) for 15 min at RT and
spun down, this fixation step was repeated four times. The suspension of cells in
Carnoy’s buffer (100 ml) was dropped on a clean slide from about 80 cm distance
and let dry at RT. Slides were incubated with 3% Giemsa in PBS for 6 min at RT.
After drying, slides were mounted with DPX mountant (Sigma).
Data availability. The authors declare that the data supporting the findings of this
study are available within the paper and its Supplementary Information files or
from the authors upon request.
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